CENTURA
Live / Allowed — Fourth extension granted (statement of use) (as of 01 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Feb 2021 filing date already counts against anyone who files later.
Record
- Serial number
- 90548602
- Mark type
- Word mark
- Filed
- 26 Feb 2021
- Published for opposition
- 06 Feb 2024
- Attorney of record
- Karen L. Elbing
Goods and services
- Class 005 — Pharmaceuticals: Topical insulin preparations for the treatment and prevention of skin wounds
Owner
- ELEOS PHARMACEUTICALS, INC., WATKINSVILLE, GA, US
- ELEOS PHARMACEUTICALS, INC., WATKINSVILLE, GA, US
- Eleos Pharmaceuticals, LLC, Watkinsville, GA, US
Prosecution history
- 25 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2026 — SOU EXTENSION 4 GRANTED
- 01 Apr 2026 — SOU EXTENSION 4 FILED
- 01 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2025 — SOU EXTENSION 3 GRANTED
- 01 Oct 2025 — SOU EXTENSION 3 FILED
- 01 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2025 — SOU EXTENSION 2 GRANTED
- 01 Apr 2025 — SOU EXTENSION 2 FILED
- 01 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2024 — SOU EXTENSION 1 GRANTED